Subsequently, the elevated CXCL2 secretion from tumor cells promotes the recruitment of myeloid‐derived suppressor cells (MDSCs) into the tumor microenvironment (TME) through C‐X‐C chemokine receptor type 2 (CXCR2), thereby facilitating CRC progression. This evidence concerns the gene CXCL2 and colorectal carcinoma.